Isolated systolic hypertension: To treat or not to treat' and the role of central haemodynamics

Journal of Hypertension

Volumn 31, Issue 4, 2013, Pages 655-658

  Protogerou, Athanase D ^a   Blacher, Jacques ^b   Safar, Michel E ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b Centre de Diagnostic et de Therapeutique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; AORTA PRESSURE; BRACHIAL PULSE PRESSURE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; HEART HEMODYNAMICS; HUMAN; ISOLATED SYSTOLIC HYPERTENSION; NOTE; PHENOTYPE; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC HYPERTENSION;

EID: 84875195967     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835f7e2b     Document Type: Note

References (33)

1. O'Rourke MF, Adji A. Guidelines on guidelines: focus on isolated systolic hypertension in youth. J Hypertens 2013; 31:649-654.
2. Nichols WW, O'Rourke MF, Vlachopoulos C. McDonald's blood flow in arteries: theoretical, experimental and clinical principles, 6th ed. London: Edward Arnold; 2012.
3. Safar ME, Balkau B, Lange C, Protogerou AD, Czernichow S, Blacher J, et al. Hypertension and vascular dynamics in men and women with metabolic syndrome. J Am Coll Cardiol 2013; 61:12-19.
4. Franklin SS, Jacobs MJ, Wong ND, L' Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37:869- 874.
5. Grebla RC, Rodriguez CJ, Borrell LN, Pickering TG. Prevalence and determinants of isolated systolic hypertension among young adults: the 1999-2004 US National Health And Nutrition Examination Survey. J Hypertens 2010; 28:15-23.
6. Wallace SM, Yasmin, McEniery CM, Ma?ki-Peta?ja? KM, Booth AD, Cockcroft JR, Wilkinson IB. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 2007; 50:228-233.
7. O'Rourke MF, Vlachopoulos C, Graham RM. Spurious systolic hypertension in youth. Vasc Med 2000; 5:141-145.
8. Mahmud A, Feely J. Spurious systolic hypertension of youth: fit young men with elastic arteries. Am J Hypertens 2003; 16:229-232.
9. McEniery CM, Yasmin, Wallace S, Maki-213 Petaja K, McDonnell B, Sharman JE, et al.; ENIGMA Study Investigators. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension 2005; 46:221-226.
10. Hulsen HT, Nijdam ME, Bos WJ, Uiterwaal CS, Oren A, Grobbee DE, Bots M. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants. J Hypertens 2006; 24:1027-1032.
11. Saladini F, Santonastaso M, Mos L, Benetti E, Zanatta N, Maraglino G, Palatini P, HARVEST Study Group. Isolated systolic hypertension of young-to-middle-age individuals implies a relatively low risk of developing hypertension needing treatment when central blood pressure is low. J Hypertens 2011; 29:1311-1319.
12. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, et al. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 2009; 54:375-383.
13. Blacher J, Protogerou AD, Safar ME. Cardiovascular risk and the macrocirculation. In: Safar ME, editor. Macro- and microcirculation in hypertension. London: Lippincott Williams & Wilkins; 2005. pp. 83-97.
14. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
15. Protogerou AD, Blacher J, Stergiou GS, Achimastos A, Safar ME. Blood pressure response under chronic antihypertensive drug treatment. The role of aortic stiffness in the REASON study. J Am Coll Cardiol 2009; 53:445-451.
16. Protogerou AD, Safar ME, Iaria P, Safar H, Le DK, Filipovsky J, et al. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 2007; 50:172-180.
17. Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: Evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des 2009; 15:272-289.
18. Jamerson K, Weber MA, Bakris GL, Dahlo?f B, Pitt B, Shi V, et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417-2428.
19. Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C, et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol 2010; 55:1032-1037.
20. Benetos A, Gautier S, Labat C, Salvi P, Valbusa F, Marino F, et al. Mortality and cardiovascular events are best predicted by low central/ peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study. J Am Coll Cardiol 2012; 60:1503-1511.
21. Protogerou AD, Safar ME, Papaioannou TG, Zhang Y, Agnoletti D, Papadogiannis D, Blacher J. The combined effect of aortic stiffness and pressure wave reflections on mortality in the very old with cardiovascular disease: the PROTEGER Study. Hypertens Res 2011; 34:803-808.
22. Protogerou AD, Smulyan H, Safar ME. Closer to noninvasive out-ofoffice aortic blood pressure assessment: a time to think and act. Hypertension 2011; 58:765-767.
23. Papaioannou TG, Protogerou AD, Stefanadis C. What to anticipate from pulse pressure amplification. J Am Coll Cardiol 2010; 55:1038- 1040.
24. Simon AC, Safar ME, Levenson JA, Kheder AM, Levy BI. Systolic hypertension: hemodynamic mechanism and choice of antihypertensive treatment. Am J Cardiol 1979; 44:505-511.
25. Sorof JM, Poffenbarger T, Franco K, Bernard L, Portman RJ. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr 2002; 140:660-666.
26. Eich RH, Peters RJ, Cuddy RP, Smulyan H, Lyons RH. The hemodynamics in labile hypertension. Am Heart J 1962; 63:188-195.
27. Wilkinson IB, Franklin SS, Hall IR, Tyrrell S, Cockcroft Jr. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension 2001; 38:1461-1466.
28. Papaioannou TG, Protogerou AD, Stamatelopoulos KS, Vavuranakis M, Stefanadis C. Noninvasive methods and techniques for central blood pressure estimation: procedures, validation, reproducibility and limitations. Curr Pharm Des 2009; 15:245-253.
29. Wilkinson IB, McEniery CM, Cockcroft Jr. Central blood pressure estimation for the masses moves a step closer. J Hum Hypertens 2010; 24:495-497.
30. Protogerou AD, Argyris A, Nasothimiou E, Vrachatis D, Papaioannou TG, Tzamouranis D, et al. Feasibility and reproducibility of noninvasive 24-h ambulatory aortic blood pressure monitoring with a brachial cuffbased oscillometric device. Am J Hypertens 2012; 25:876-882.
31. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology.
32. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
33. Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al. European Society of Hypertension. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009; 27:1719-1742.